Ali MM, Mahmood NMA. The Use of Cyclin-Dependent Tyrosine Kinase 4/6 (CDK4/6) Inhibitors in Breast Cancer. Al-Rafidain J Med Sci [Internet]. 2022 Sept. 3 [cited 2026 Oct. 25];3:30-5. Available from: https://ajms.iq/index.php/ALRAFIDAIN/article/view/79